ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer
Newly released results from the Phase III ADAURA trial reveal that osimertinib yielded a 5.5-year…
Browsing: EGFR-mutated lung cancer
Potential drug treatment for particular type of lung-cancer
The effectiveness of cancer treatment is often hampered by cancer cells being heterogeneous. This is…